FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043829191> ?p ?o ?g. }

• W2043829191 endingPage "238" @default.
• W2043829191 startingPage "224" @default.
• W2043829191 abstract "We previously demonstrated that H2 relaxin (RLN2) facilitates castrate-resistant (CR) growth of prostate cancer (CaP) cells through PI3K/Akt/β-catenin-mediated activation of the androgen receptor (AR) pathway. As inhibition of this pathway caused only ~50% reduction in CR growth, the goal of the current study was to identify additional RLN2-activated pathways that contribute to CR growth. Next-generation sequencing-based transcriptome and gene ontology analyses comparing LNCaP stably transfected with RLN2 versus LNCaP-vector identified differential expression of genes associated with cell proliferation (12.7% of differentially expressed genes), including genes associated with the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) and nuclear factor–kappaB (NF–κB) pathways. Subsequent molecular analyses confirmed that the cAMP/PKA and NF–κB pathways play a role in facilitating H2 relaxin-mediated CR growth of CaP cells. Inhibition of PKA-attenuated RLN2-mediated AR activity inhibited proliferation and caused a small but significant increase in apoptosis. Combined inhibition of the PKA and NF–κB signaling pathways via inhibition of PKA and Akt induced significant apoptosis and dramatically reduced clonogenic potential, outperforming docetaxel, the standard of care treatment for CR CaP. Immunohistochemical analysis of tissue microarrays in combination with multispectral quantitative imaging comparing RLN2 levels in patients with benign prostatic hyperplasia (BPH), prostatic intraepithelial neoplasia, and CaP determined that RLN2 is significantly upregulated in CaP vs BPH (p = 0.002). The combined data indicate RLN2 overexpression is frequent in CaP patients and provides a growth advantage to CaP cells. A near-complete inhibition of RLN2-induced CR growth can be achieved by simultaneous blockade of both pathways." @default.
• W2043829191 created "2016-06-24" @default.
• W2043829191 creator A5000966901 @default.
• W2043829191 creator A5014531718 @default.
• W2043829191 creator A5038194485 @default.
• W2043829191 creator A5039463618 @default.
• W2043829191 creator A5042822285 @default.
• W2043829191 creator A5048911513 @default.
• W2043829191 creator A5054519317 @default.
• W2043829191 creator A5078569994 @default.
• W2043829191 date "2011-07-26" @default.
• W2043829191 modified "2023-10-17" @default.
• W2043829191 title "Dual Blockade of PKA and NF–κB Inhibits H2 Relaxin-Mediated Castrate-Resistant Growth of Prostate Cancer Sublines and Induces Apoptosis" @default.
• W2043829191 cites W1966527015 @default.
• W2043829191 cites W1969597507 @default.
• W2043829191 cites W1970127699 @default.
• W2043829191 cites W1970473792 @default.
• W2043829191 cites W1972943971 @default.
• W2043829191 cites W1984990912 @default.
• W2043829191 cites W1987004939 @default.
• W2043829191 cites W1988885942 @default.
• W2043829191 cites W1990749869 @default.
• W2043829191 cites W1992080225 @default.
• W2043829191 cites W1996038926 @default.
• W2043829191 cites W2011216433 @default.
• W2043829191 cites W2012016911 @default.
• W2043829191 cites W2016892105 @default.
• W2043829191 cites W2018594211 @default.
• W2043829191 cites W2022479819 @default.
• W2043829191 cites W2026424159 @default.
• W2043829191 cites W2027032958 @default.
• W2043829191 cites W2036721395 @default.
• W2043829191 cites W2038621648 @default.
• W2043829191 cites W2041193073 @default.
• W2043829191 cites W2043529958 @default.
• W2043829191 cites W2054045654 @default.
• W2043829191 cites W2057891123 @default.
• W2043829191 cites W2068039924 @default.
• W2043829191 cites W2070263748 @default.
• W2043829191 cites W2072345658 @default.
• W2043829191 cites W2074516894 @default.
• W2043829191 cites W2080439368 @default.
• W2043829191 cites W2087317867 @default.
• W2043829191 cites W2095609697 @default.
• W2043829191 cites W2103017472 @default.
• W2043829191 cites W2105103391 @default.
• W2043829191 cites W2111923037 @default.
• W2043829191 cites W2114319406 @default.
• W2043829191 cites W2117607600 @default.
• W2043829191 cites W2120292596 @default.
• W2043829191 cites W2133742377 @default.
• W2043829191 cites W2137652355 @default.
• W2043829191 cites W2151378093 @default.
• W2043829191 cites W2152736965 @default.
• W2043829191 cites W2154052817 @default.
• W2043829191 cites W2154431984 @default.
• W2043829191 cites W2155470210 @default.
• W2043829191 cites W2162561140 @default.
• W2043829191 cites W2167570951 @default.
• W2043829191 cites W2167888953 @default.
• W2043829191 cites W2316386966 @default.
• W2043829191 cites W4241969355 @default.
• W2043829191 doi "https://doi.org/10.1007/s12672-011-0076-4" @default.
• W2043829191 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3249648" @default.
• W2043829191 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21789713" @default.
• W2043829191 hasPublicationYear "2011" @default.
• W2043829191 type Work @default.
• W2043829191 sameAs 2043829191 @default.
• W2043829191 citedByCount "32" @default.
• W2043829191 countsByYear W20438291912012 @default.
• W2043829191 countsByYear W20438291912013 @default.
• W2043829191 countsByYear W20438291912014 @default.
• W2043829191 countsByYear W20438291912015 @default.
• W2043829191 countsByYear W20438291912016 @default.
• W2043829191 countsByYear W20438291912017 @default.
• W2043829191 countsByYear W20438291912018 @default.
• W2043829191 countsByYear W20438291912019 @default.
• W2043829191 countsByYear W20438291912020 @default.
• W2043829191 countsByYear W20438291912021 @default.
• W2043829191 countsByYear W20438291912022 @default.
• W2043829191 countsByYear W20438291912023 @default.
• W2043829191 crossrefType "journal-article" @default.
• W2043829191 hasAuthorship W2043829191A5000966901 @default.
• W2043829191 hasAuthorship W2043829191A5014531718 @default.
• W2043829191 hasAuthorship W2043829191A5038194485 @default.
• W2043829191 hasAuthorship W2043829191A5039463618 @default.
• W2043829191 hasAuthorship W2043829191A5042822285 @default.
• W2043829191 hasAuthorship W2043829191A5048911513 @default.
• W2043829191 hasAuthorship W2043829191A5054519317 @default.
• W2043829191 hasAuthorship W2043829191A5078569994 @default.
• W2043829191 hasBestOaLocation W20438291912 @default.
• W2043829191 hasConcept C121608353 @default.
• W2043829191 hasConcept C126322002 @default.
• W2043829191 hasConcept C134018914 @default.
• W2043829191 hasConcept C185592680 @default.
• W2043829191 hasConcept C2779723316 @default.
• W2043829191 hasConcept C2780192828 @default.
• W2043829191 hasConcept C502942594 @default.

• next